DROPBOT

Serial Number 99127459
661

Registration Progress

Application Filed
Apr 8, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Attorney Assistance

Non-Final Action E-Mailed
Due: Jan 06, 2026 13 days

Trademark Image

DROPBOT

Basic Information

Serial Number
99127459
Filing Date
April 8, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
661
Status Date
Dec 19, 2025
Application
Pending
Classes
009 010

Rights Holder

Sci-bots Inc.

03
Address
277 Richmond St. W.
Suite 200
Toronto, ON M5V 1X1

Ownership History

Sci-bots Inc.

Original Applicant
03
Toronto, ON

Legal Representation

Attorney
Danielle Cohen

USPTO Deadlines

Next Deadline
13 days remaining
Non-Final Action E-Mailed
Due Date
January 06, 2026
Extension Available
Until April 06, 2026

Application History

10 events
Date Code Type Description Documents
Dec 19, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 19, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 19, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 6, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 6, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 6, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 4, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 11, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 8, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Apr 8, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 009
Laboratory, scientific, optical, and electrical research apparatus and instruments, namely, digital microfluidic platforms comprised primarily of computer hardware and also including recorded computer software for automating sample preparation, droplet manipulation, and data analysis in laboratory workflows, microchannel wafers, and sensor chips for use in the fields of laboratory, scientific, optical and electrical research; Digital microfluidic platforms comprised primarily of computer hardware and also including recorded computer software for automating sample preparation, droplet manipulation, and data analysis in laboratory workflows, microchannel wafers, and sensor chips for use in the fields of laboratory, scientific, optical and electrical research; Digital microfluidic platforms comprised primarily of computer hardware and also including recorded computer software for use in automating sample preparation, droplet manipulation, and data analysis in laboratory workflows, microchannel wafers, and sensor chips for use in the fields of laboratory, scientific, optical and electrical research; Digital microfluidic platforms comprised primarily of computer hardware and also including recorded computer software for biological, genetic, chemical, medical, and scientific research and analysis, power controllers, and sensor chips for laboratory, scientific, optical and electrical research; Digital microfluidic platforms comprised primarily of computer hardware and also including recorded computer software for sample preparation, manipulation, and analysis in chemical and biochemical workflows for laboratory, scientific, optical and electrical research; Digital microfluidic platforms comprised primarily of computer hardware and also including recorded computer software for testing and measuring an attribute in assays for use in the fields of laboratory, scientific, optical and electrical research; Digital microfluidic platforms comprised primarily of computer hardware and also including recorded computer software for single-cell and bulk-sample analyses for identifying, isolating, capturing, sorting, imaging, counting, and analyzing cells and tissue for use in the fields of laboratory, scientific, optical and electrical research; Scientific apparatus and instruments, namely, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of biomarkers, proteins, nucleic acids, metabolites, chemical contaminants and biological contaminants; Scientific apparatus and instruments for creating, analyzing, and manipulating droplets and micro-droplets for the presence, absence, or quantity of biomarkers, proteins, nucleic acids, metabolites, chemical contaminants and biological contaminants; Kits comprising peptide substrates for preparing samples for chemical analysis, biochemical analysis, imaging microfluidic analysis, and digital microfluidic analysis; Data processing equipment for use with apparatus and instruments for creating, analysing and manipulating droplets and micro-droplets; Downloadable software for chemical and biochemical analysis in the field of scientific imaging and microfluidics; Downloadable computer software and embedded firmware for configuring, operating, and analyzing data from digital microfluidic platforms used in chemical, biochemical, and medical assays; Scientific research platform device comprised primarily of computer hardware and also including recorded software for single-cell and bulk-sample analyses for identifying, isolating, capturing, sorting, imaging, counting, and analyzing cells and tissue for use in the fields of laboratory, scientific, optical and electrical research; Scientific research platform device comprised primarily of computer hardware and recorded software for use in automating sample preparation, droplet manipulation, and data analysis in laboratory workflows; Downloadable scientific and medical data and information to enable for use in chemical analysis, biochemical analysis and microfluidic analysis; Electronic circuit boards for use as controllers for digital microfluidic platform devices; Scientific laboratory research instruments for use with digital microfluidic applications in the field of medical imaging; Microscopes for use with digital microfluidic chips; Integrated digital microfluidic platforms comprised primarily of computer hardware and also including recorded computer software for sample preparation for use with external analytical instruments, namely, instruments for mass spectrometry, instruments for fluorescence spectroscopy, electrochemical sensors, and nucleic acid sequencing instruments ; Remote controls for digital microfluidic platform devices and sensor chips for digital microfluidic platform devices for scientific use; Automated liquid handling systems comprised primarily of computer hardware, electronic controllers, sensor chips, and recorded computer software for automating sample preparation, droplet manipulation, and fluid dispensing in digital microfluidic workflows, and laboratory consumables, namely, pipette tips for digital microfluidic workflows; Automated liquid handling systems comprised primarily of computer hardware, electronic controllers, sensor chips, and recorded computer software for automating sample preparation, droplet manipulation, and fluid dispensing in digital microfluidic workflows; Computer hardware and downloadable computer software for controlling automated liquid handling systems; Digital microfluidic platforms comprised primarily of computer hardware and also including recorded computer software for use in agricultural testing, environmental testing and food testing for laboratory, scientific, optical and electrical research
First Use Anywhere: Nov 6, 2017
First Use in Commerce: Nov 6, 2017
Class 010
Medical devices, namely, digital microfluidic platforms for in vitro diagnostic testing of patient samples for the diagnosis and monitoring of hematologic disorders, coagulation disorders, infectious diseases, metabolic disorders, cardiovascular disorders, inflammatory disorders, immunologic disorders, genetic disorders, and for blood transfusion compatibility testing, namely, blood group typing; Medical devices, namely, digital microfluidic platforms for sample preparation and analysis in medical and clinical research and for chemical assays, biochemical assays, and clinical diagnostics in laboratory settings for the diagnosis and monitoring of hematologic disorders, coagulation disorders, infectious diseases, metabolic disorders, cardiovascular disorders, inflammatory disorders, immunologic disorders, genetic disorders, and for blood transfusion compatibility testing, namely, blood group typing; Digital microfluidic platforms for research use in medical and life sciences applications, for cellular and molecular analysis in research and laboratory settings, and for point-of-care diagnostic testing for the diagnosis and monitoring of hematologic disorders, coagulation disorders, infectious diseases, metabolic disorders, cardiovascular disorders, inflammatory disorders, immunologic disorders, genetic disorders, and for blood transfusion compatibility testing, namely, blood group typing; AI-assisted digital microfluidic platforms for automated biomarker detection for the diagnosis and monitoring of hematologic disorders, coagulation disorders, infectious diseases, metabolic disorders, cardiovascular disorders, inflammatory disorders, immunologic disorders, genetic disorders, and for blood transfusion compatibility testing, namely, blood group typing; Apparatus and instruments for droplet chemical and biochemical analysis for medical diagnostic purposes; Laboratory-based instruments and consumables in the nature of digital microfluidic medical analyzers and disposable medical diagnostic cartridges for medical sample preparation and analysis, namely, biomarker detection, cytokine profiling, nucleic acid analysis, and therapeutic drug monitoring for the diagnosis and monitoring of hematologic disorders, coagulation disorders, infectious diseases, metabolic disorders, cardiovascular disorders, inflammatory disorders, immunologic disorders, genetic disorders, and for blood transfusion compatibility testing, namely, blood group typing; Digital microfluidic chips for use in medical applications, namely, detecting biomarkers, performing immunoassays, and point-of-care diagnostic tests for the diagnosis and monitoring of hematologic disorders, coagulation disorders, infectious diseases, metabolic disorders, cardiovascular disorders, inflammatory disorders, immunologic disorders, genetic disorders, and for blood transfusion compatibility testing, namely, blood group typing
First Use Anywhere: Nov 6, 2017
First Use in Commerce: Nov 6, 2017

Classification

International Classes
009 010